NanoViricides

Longeveron Inc. (NASDAQ: LGVN) announced that the European Patent Office (EPO) had issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to methods to treat endothelial dysfunction and monitor the efficacy of allogeneic mesenchymal cell therapies, also...

Longeveron Inc. (NASDAQ: LGVN) announced that the European Patent Office (EPO) had issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to methods to treat endothelial dysfunction and monitor the efficacy of allogeneic mesenchymal cell therapies, also...

More than 30,000 confirmed or suspected cases of monkeypox have been reported across 93 countries in the world. While those numbers are still small scientists are now concerned that this sudden and unusual outbreak could lead to monkeypox becoming endemic in these large numbers of new countries...

NanoViricides, Inc. (NYSE American: NNVC) reports that it has begun drug development to combat the monkeypox virus. Specifically, the company has initiated a program to screen its library of broad-spectrum antiviral nanoviricides against certain poxviruses in order to develop broad-spectrum...

Over the two years since COVID-19 first appeared, people everywhere are becoming less vigilant perhaps simply because they are exhausted. Governments also are easing up on social distancing and mask mandates as they try to regain a sense of normalcy and stability. Meanwhile, the virus has been...

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. In medicine, nanotechnology or “nanotech” is being used to develop biological devices and machines that are assisting scientists to create more...

Image sourced from Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. NanoViricides, Inc. (NYSE American: NNVC) recently reported that it had begun drug development to combat recent cases of severe...

Photo Credit: Photo by CDC & Klara Kulikova  This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Shingles infections have been steadily increasing in the United States over the past two decades,...

Photo credit: Marcelo Leal and Kate Hliznitsova on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. In January, the U.S. Food and Drug Administration (FDA) revoked its emergency use authorization (...

Image provided by Pixabay This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Omicron is tearing through the globe, causing spikes in case numbers as well as fatalities that are outpacing even the worst surges...

Image provided by Pixabay This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. As the threat of a more rapidly spreading COVID variant Omicron casts uncertainty across global markets once again, scientists and...

Image provided by Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. NanoViricides Inc. (NYSE: NNVC) is a nanomedicine technology company that has been developing antiviral therapies...

Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The biotech industry has outperformed the S&P 500 for the last 2 years, growing by 62% compared to the S...

Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The day after Thanksgiving, the World Health Organization (WHO) designated COVID-19 variant B.1.1.529 as a...